IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding IDEAYA Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 157 | 204 | +47 |
| Shares | 66.1M | 79.1M | +12.9M (+19.6%) |
| Value | $2.35B | $3.47B | +$1.12B (+47.4%) |
New holders (59)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (12)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Balyasny Asset Management LLC | 466,271 | $16.6M |
| Opaleye Management Inc. | 311,500 | $11.1M |
| Nantahala Capital Management, LLC | 139,298 | $4.96M |
| Trexquant Investment LP | 21,984 | $782.2K |
| Jefferies Financial Group Inc. | 17,500 | $622.6K |
| Virtu Financial LLC | 16,369 | $582.0K |
| Y-Intercept (Hong Kong) Ltd | 14,218 | $505.9K |
| Walleye Trading LLC | 12,589 | $447.9K |
| Fox Run Management, L.L.C. | 6,845 | $243.5K |
| Jump Financial, LLC | 6,045 | $215.1K |
| BIT Capital GmbH | 4,237 | $150.8K |
| AJOVista, LLC | 2,778 | $98.8K |